References
- Newman S P. Scintigraphic assessment of therapeutic aerosols. Crit Rev Ther Drug Carrier Syst 1993; 10: 65
- Newman S P, Clark A R, Talaee N, Clarke S W. Pressurised aerosol deposition in the human lung with and without an “open” spacer. Thorax 1989; 44: 706
- Brown P H, Blundell G, Greening A P, Crompton G K. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids. Thorax 1990; 45: 736
- Meeran K, Burrin J M, Noonan K A, Price C P, Ind P W. A large volume spacer significantly reduces the effect of inhaled steroids on bone formation. Postgrad Med J 1995; 72: 156
- Bell J. International development of portable inhalers. J Invest Allergol Clin Immunol 1997; 7: 417
- Ganderton D. General factors influencing drug delivery to the lung. Respir Med 1997; 92: 13, Suppl A
- Morice A H, Peake M D, Allen M B, Campbell J H, Parry-Billings M. Reproducibility of bronchodilator response for a reservoir dry powder inhaler following routine clinical use. J Asthma 2000; 37: 81
- O'Callaghan C, Everard M L, Ross Russell R I, Bush A, O'Keeffe P. Efficacy and safety of salbutamol delivered by a novel multidose dry powder inhaler (DPI) and a pressurized metered dose inhaler (MDI) in paediatric asthma. Eur Respir J 1997; 16: 126, Suppl
- Newhouse M T, Nantel N P, Chambers C, Pratt B, Parry-Billings M. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates. Chest 1999; 115: 952
- Stradling J R, Pearson M G. Efficacy of beclomethasone dipropionate delivered via a novel dry powder inhaler (Clickhaler®). Am J Respir Crit Care Med 1998; 157: A639
- Kamada A K, Szefler S J. How should inhaled glucocorticoids be compared. J Allergy Clin Immunol 1997; 99: 735
- Bootsma G P, Dekhuijzen P NR, Festen J, Mulder P GH, Van Herwaarden C LA. Comparison of fluticasone propionate and beclomethasone diproprionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma. Thorax 1995; 50: 1044
- Kharitonov S A, Yates D H, Chung K F, Barnes P J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9: 196
- Venge P. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Respir Med 1995; 89: 1
- Pavord I D, Pizzichini M MM, Pizzichini E, Hargreave F E. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52: 498
- Barnes N C, Marone G, Di Maria G U, Visser S, Utama I, Payne S L. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir J 1993; 6: 877
- Holliday S M, Faulds D, Sorkin E M. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs 1994; 47: 318
- Society of Pharmaceutical Medicine. Clinical development of drugs against asthma. J Pharm Med 1993; 3: 193
- Morice A H, Stradling J, Barnes N C. Assessment of the acceptability of a new multidose dry powder inhaler in patients with asthma. Eur Respir J 1997; 16: 126, Suppl
- Allen M B, Ward M J, Morice A H. Clickhaler®, a novel multidose dry powder inhaler has high acceptability in patients with asthma. Thorax 1997; 52: 105, Suppl
- Adler L M, Clarke I C. Efficacy and safety of beclomethasone diproprionate (BDP) delivered via a novel dry powder inhaler (Clickhaler®) in paediatric patients with asthma. Thorax 1997; 52: 106, Suppl